Thyroid replacement therapy and heart failure.
Gerdes
Anthony Martin
AM
Cardiovascular Health Research Center, Sanford Research/University of South Dakota, 1100 E 21st Street, Sioux Falls, SD 57105, USA. mgerdes@usd.edu
Iervasi
Giorgio
G
D000818:Animals; D002318:Cardiovascular Diseases / Q000209:etiology; D004104:Diiodothyronines / Q000627:therapeutic use; D004195:Disease Models, Animal; D005919:Glomerular Filtration Rate; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006706:Homeostasis; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000503:physiopathology; D007037:Hypothyroidism / Q000150:complications / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology; D032342:Muscle Cells / Q000166:cytology; D009200:Myocardial Contraction / Q000502:physiology; D009203:Myocardial Infarction / Q000097:blood; D045265:Natriuretic Peptides / Q000097:blood / Q000502:physiology; D011422:Propionates / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000097:blood* / Q000627:therapeutic use; D013974:Thyroxine / Q000502:physiology; D014284:Triiodothyronine / Q000097:blood; D014664:Vasodilation
D004104:Diiodothyronines; D045265:Natriuretic Peptides; D011422:Propionates; D013963:Thyroid Hormones; D014284:Triiodothyronine; C082182:3,5-diiodothyropropionic acid; D013974:Thyroxine